Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,524
Sort by:
Cervical Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Cervical Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cervical Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
1460 pages
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Cytomegalovirus (HHV-5) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cytomegalovirus (HHV-5) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
191 pages
Endometrial Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Endometrial Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Endometrial Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
1456 pages
Ewing Sarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ewing Sarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ewing Sarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
701 pages
Gouty Arthritis (Gout) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Gouty Arthritis (Gout) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gouty Arthritis (Gout) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
125 pages
Insomnia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Insomnia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Insomnia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
158 pages
Irritable Bowel Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Irritable Bowel Syndrome (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Irritable Bowel Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
160 pages
Melanoma - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
999 pages
Migraine - Pipeline Review, H1 2020
US$ 2,000.00
... . The Migraine (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Migraine and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
313 pages
Neuroblastoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Neuroblastoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Neuroblastoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
915 pages
Obesity - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Obesity (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Obesity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
592 pages
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Respiratory Syncytial Virus (RSV) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
292 pages
Spinal Cord Injury - Pipeline Review, H1 2020
US$ 2,000.00
... . The Spinal Cord Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Cord Injury and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
243 pages
Systemic Lupus Erythematosus - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Systemic Lupus Erythematosus (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Lupus Erythematosus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
717 pages
Tuberculosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Tuberculosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tuberculosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
405 pages
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2020
US$ 2,000.00
... The Vancomycin-Resistant Enterococcus faecium Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Vancomycin-Resistant Enterococcus faecium Infections and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
96 pages
Cancer Pain - Pipeline Review, H1 2020
US$ 2,000.00
... . The Cancer Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cancer Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
155 pages
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Lymphocytic Leukemia (CLL) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
1353 pages
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chronic Myelocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
598 pages
Diabetic Foot Ulcers - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Foot Ulcers (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Foot Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
182 pages
Diabetic Neuropathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diabetic Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
135 pages
Diabetic Retinopathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diabetic Retinopathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Retinopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
324 pages
Hypercholesterolemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypercholesterolemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypercholesterolemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
252 pages
Malaria - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Malaria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Malaria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
394 pages
Prostate Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Prostate Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Prostate Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
2967 pages
Psoriatic Arthritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Psoriatic Arthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Psoriatic Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
282 pages
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2020
US$ 2,500.00
... . The Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type1 diabetes (Juvenile Diabetes) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
672 pages
Type 2 Diabetes - Pipeline Review, H1 2020
US$ 2,500.00
... . The Type 2 Diabetes (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type2 diabetes and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
1220 pages
Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Leishmaniasis (Kala-Azar) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Leishmaniasis (Kala-Azar) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
140 pages
Non-Hodgkin Lymphoma - Pipeline Review, H1 2020
US$ 2,500.00
... Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Non-Hodgkin Lymphoma (Oncology) The guide covers the ...
May 2020
3473 pages
Schizophrenia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Schizophrenia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Schizophrenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
383 pages
Escherichia coli Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Escherichia coli Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Escherichia coli Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
200 pages
Diphtheria - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diphtheria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Diphtheria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
85 pages
Hepatitis B - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatitis B (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis B and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
503 pages
Muscular Dystrophy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Muscular Dystrophy (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
250 pages
Aplastic Anemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Aplastic Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Aplastic Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
110 pages
Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Herpes Labialis (Oral Herpes) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
61 pages
Tularaemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Tularaemia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tularaemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
40 pages
Cryptosporidiosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cryptosporidiosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptosporidiosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
30 pages
Osteonecrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Osteonecrosis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteonecrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
31 pages
Gliosarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gliosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gliosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
350 pages
Hypoparathyroidism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypoparathyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoparathyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
70 pages
Pemphigus Vulgaris - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pemphigus Vulgaris (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Pemphigus Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
92 pages
Systemic Mastocytosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Systemic Mastocytosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Systemic Mastocytosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
178 pages
Anaphylaxis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Anaphylaxis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Anaphylaxis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
58 pages
Gallbladder Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gallbladder Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gallbladder Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
695 pages
